NICE Rethink over lung cancer drug Tarceva - The Telegraph 2nd October 2007

Lung cancer sufferers could be given access to a treatment believed to extend life expectancy after the Government's health watchdog agreed to review a previous decision to deny NHS patients the drug. Tarceva is a once-daily tablet designed to treat non-small cell lung cancer – the most common form of the disease – if initial attempts to treat it with chemotherapy fail.

Link to Article